These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 18275279)

  • 21. Murine model for dengue virus-induced lethal disease with increased vascular permeability.
    Shresta S; Sharar KL; Prigozhin DM; Beatty PR; Harris E
    J Virol; 2006 Oct; 80(20):10208-17. PubMed ID: 17005698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterologous T cell immunity in severe hepatitis C virus infection.
    Urbani S; Amadei B; Fisicaro P; Pilli M; Missale G; Bertoletti A; Ferrari C
    J Exp Med; 2005 Mar; 201(5):675-80. PubMed ID: 15753202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dengue-specific CD8+ T cells have both protective and pathogenic roles in dengue virus infection.
    An J; Zhou DS; Zhang JL; Morida H; Wang JL; Yasui K
    Immunol Lett; 2004 Sep; 95(2):167-74. PubMed ID: 15388257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand.
    Endy TP; Nisalak A; Chunsuttitwat S; Vaughn DW; Green S; Ennis FA; Rothman AL; Libraty DH
    J Infect Dis; 2004 Mar; 189(6):990-1000. PubMed ID: 14999601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serological markers during dengue 3 primary and secondary infections.
    Vázquez S; Pérez AB; Ruiz D; Rodríguez R; Pupo M; Calzada N; González L; González D; Castro O; Serrano T; Guzmán MG
    J Clin Virol; 2005 Jun; 33(2):132-7. PubMed ID: 15911428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamics of cellular immune responses in the acute phase of dengue virus infection.
    Yoshida T; Omatsu T; Saito A; Katakai Y; Iwasaki Y; Kurosawa T; Hamano M; Higashino A; Nakamura S; Takasaki T; Yasutomi Y; Kurane I; Akari H
    Arch Virol; 2013 Jun; 158(6):1209-20. PubMed ID: 23381396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibodies from dengue patient sera cross-react with endothelial cells and induce damage.
    Lin CF; Lei HY; Shiau AL; Liu CC; Liu HS; Yeh TM; Chen SH; Lin YS
    J Med Virol; 2003 Jan; 69(1):82-90. PubMed ID: 12436482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effector T-cell differentiation during viral and bacterial infections: Role of direct IL-12 signals for cell fate decision of CD8(+) T cells.
    Keppler SJ; Theil K; Vucikuja S; Aichele P
    Eur J Immunol; 2009 Jul; 39(7):1774-83. PubMed ID: 19548244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dengue virus infection and immune response in humanized RAG2(-/-)gamma(c)(-/-) (RAG-hu) mice.
    Kuruvilla JG; Troyer RM; Devi S; Akkina R
    Virology; 2007 Dec; 369(1):143-52. PubMed ID: 17707071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Slower rates of clearance of viral load and virus-containing immune complexes in patients with dengue hemorrhagic fever.
    Wang WK; Chen HL; Yang CF; Hsieh SC; Juan CC; Chang SM; Yu CC; Lin LH; Huang JH; King CC
    Clin Infect Dis; 2006 Oct; 43(8):1023-30. PubMed ID: 16983615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dengue virus-induced autoantibodies bind to plasminogen and enhance its activation.
    Chuang YC; Lei HY; Lin YS; Liu HS; Wu HL; Yeh TM
    J Immunol; 2011 Dec; 187(12):6483-90. PubMed ID: 22079981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kinetics of primary and memory cytotoxic T lymphocyte responses to herpes simplex virus 1 infection: granzyme B mediated CTL activity.
    Gorgian Mohammadi M; Bamdad T; Parsania M; Hashemi HR; Puyanfard S
    Iran J Immunol; 2009 Mar; 6(1):22-7. PubMed ID: 19293474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated levels of total and dengue virus-specific immunoglobulin E in patients with varying disease severity.
    Koraka P; Murgue B; Deparis X; Setiati TE; Suharti C; van Gorp EC; Hack CE; Osterhaus AD; Groen J
    J Med Virol; 2003 May; 70(1):91-8. PubMed ID: 12629649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody-dependent enhancement of dengue virus infection in U937 cells requires cholesterol-rich membrane microdomains.
    Puerta-Guardo H; Mosso C; Medina F; Liprandi F; Ludert JE; del Angel RM
    J Gen Virol; 2010 Feb; 91(Pt 2):394-403. PubMed ID: 19828759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modelling the relationship between antibody-dependent enhancement and immunological distance with application to dengue.
    Adams B; Boots M
    J Theor Biol; 2006 Sep; 242(2):337-46. PubMed ID: 16631802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dengue virus-reactive CD8+ T cells display quantitative and qualitative differences in their response to variant epitopes of heterologous viral serotypes.
    Bashyam HS; Green S; Rothman AL
    J Immunol; 2006 Mar; 176(5):2817-24. PubMed ID: 16493038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection.
    Guzman MG; Alvarez M; Halstead SB
    Arch Virol; 2013 Jul; 158(7):1445-59. PubMed ID: 23471635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective Role of Cross-Reactive CD8 T Cells Against Dengue Virus Infection.
    Elong Ngono A; Chen HW; Tang WW; Joo Y; King K; Weiskopf D; Sidney J; Sette A; Shresta S
    EBioMedicine; 2016 Nov; 13():284-293. PubMed ID: 27746192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secondary heterologous dengue infection risk: Disequilibrium between immune regulation and inflammation?
    Sierra B; Perez AB; Vogt K; Garcia G; Schmolke K; Aguirre E; Alvarez M; Kern F; Kourí G; Volk HD; Guzman MG
    Cell Immunol; 2010; 262(2):134-40. PubMed ID: 20219186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a novel DNA SynCon tetravalent dengue vaccine that elicits immune responses against four serotypes.
    Ramanathan MP; Kuo YC; Selling BH; Li Q; Sardesai NY; Kim JJ; Weiner DB
    Vaccine; 2009 Oct; 27(46):6444-53. PubMed ID: 19580892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.